Hepatology

Mouse study finds impaired ammonia clearance can accelerate hepatocellular carcinoma growth and highlights potential dietary strategies to slow tumours.

Post-COVID chronic liver complications, including fibrosis and cirrhosis, have been reported months after infection, highlighting long-term risks.

Multicentre study in South America suggests MASLD is a leading cause of cirrhosis, highlighting rising metabolic risk factors and gender-balanced insights.

Abnormal Wnt signalling may drive a rare, high-risk childhood liver cancer and influence chemotherapy response, new research suggests.

Genetically higher FGF21 levels were associated with lower problematic alcohol use, fewer binge episodes, reduced weekly alcohol intake, and lower ARLD risk.

HBV vaccination rates among infants in the USA have fallen by more than 10 percentage points in the past two years.

A new blood test accurately identifies serious scarring in patients with liver disease, a 2026 cohort study has found.

Since high levels of alanine aminotransferase are a significant biomarker of liver injury, this analysis points to the benefits of resistance exercise in patients with MASLD, which led to a noticeable decline in alanine aminotransferase levels.